Showing 18,581 - 18,600 results of 42,989 for search '(( 50 ((a decrease) OR (greater decrease)) ) OR ( e ((mean decrease) OR (point decrease)) ))', query time: 1.20s Refine Results
  1. 18581

    A Top-Down Proteomics Platform Coupling Serial Size Exclusion Chromatography and Fourier Transform Ion Cyclotron Resonance Mass Spectrometry by Trisha Tucholski (3992264)

    Published 2019
    “…Notably, within a 5 <i>m</i>/<i>z</i> window, we obtained baseline isotopic resolution for 6 distinct large proteoforms (30–50 kDa). …”
  2. 18582

    DataSheet5_Peripheral proteomic changes after electroconvulsive seizures in a rodent model of non-response to chronic fluoxetine.pdf by Rodolphe H. Lebeau (14031246)

    Published 2022
    “…A 50% decrease in emotionality score threshold before and after Flx, was used to separate Flx-responding mice (Flx-R, n = 18), or Flx non-responder mice (Flx-NR, n = 7). …”
  3. 18583

    DataSheet3_Peripheral proteomic changes after electroconvulsive seizures in a rodent model of non-response to chronic fluoxetine.PDF by Rodolphe H. Lebeau (14031246)

    Published 2022
    “…A 50% decrease in emotionality score threshold before and after Flx, was used to separate Flx-responding mice (Flx-R, n = 18), or Flx non-responder mice (Flx-NR, n = 7). …”
  4. 18584

    The prevalence of cardiovascular autonomic neuropathy and its influence on post induction hemodynamic variables in patients with and without diabetes; A prospective cohort study by Jorinde A. W. Polderman (6009083)

    Published 2018
    “…Primary outcomes were the prevalence of CAN and the relation between CAN and severe post-induction hypotension, defined as mean arterial pressure (MAP) < 50 mmHg or ≥ 50% decrease from baseline. Secondary outcomes were the relation between CAN, intraoperative hypotension, MAP < 65 mmHg for more than 13 minutes, and the use of vasopressor therapy.…”
  5. 18585

    DataSheet2_Peripheral proteomic changes after electroconvulsive seizures in a rodent model of non-response to chronic fluoxetine.PDF by Rodolphe H. Lebeau (14031246)

    Published 2022
    “…A 50% decrease in emotionality score threshold before and after Flx, was used to separate Flx-responding mice (Flx-R, n = 18), or Flx non-responder mice (Flx-NR, n = 7). …”
  6. 18586

    Table2_Effectiveness and Safety of Iguratimod Monotherapy or Combined With Methotrexate in Treating Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.DOCX by Dan Ouyang (554436)

    Published 2022
    “…Pooled results demonstrated as follows: 1) Compared with methotrexate (MTX) alone, IGU alone was superior in improving ACR20 and DAS28-ESR, while having no significant difference in ACR50 and ACR70 [ACR20: (RR 1.15, 95% CI 1.05–1.27, p = 0.004); ACR50: (RR 0.97, 95% CI 0.66–1.44, p = 0.88); ACR70: (RR 0.92, 95% CI 0.45–1.90, p = 0.83); DAS28-ESR: mean difference (MD) −0.15, 95% CI −0.27 to −0.03, p = 0.01]. 2) Compared with MTX alone, IGU + MTX was more effective in improving ACR20, ACR50, ACR70, and DAS28-ESR. …”
  7. 18587

    Metformin requires transcription factor SKN-1 to increase median lifespan, via a mechanism that acts in both ASI neurons and the intestine. by Brian Onken (86790)

    Published 2010
    “…Pooled data for <i>skn-1(zu135)</i> mutants expressing <i>skn-1::gfp</i> only in the ASI neurons show a median lifespan decrease from 16 days for animals on 0 mM metformin to 13 days for animals on 50 mM metformin, with a significantly left-shifted survival curve (<i>P</i><0.0001 by the Log-rank test, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0008758#pone.0008758.s005" target="_blank">Table S1G</a>). …”
  8. 18588

    Galunisertib (LY2157299), a transforming growth factor-β receptor I kinase inhibitor, attenuates acute pancreatitis in rats by X. Liu (589632)

    Published 2019
    “…<div><p>Galunisertib (LY2157299), a selective ATP-mimetic inhibitor of TGF-β receptor I (TGF-βRI), is the only known TGF-β pathway inhibitor. …”
  9. 18589

    DataSheet_1_A first-in-human, open-label, dose-escalation and dose-expansion phase I study to evaluate the safety, tolerability, pharmacokinetics/pharmacodynamics, and antitumor ac... by Zhiyu Huang (638377)

    Published 2023
    “…Background<p>QL1604 is a humanized immunoglobulin G4 monoclonal antibody against programmed cell death protein 1. …”
  10. 18590
  11. 18591

    Evidence of local mechanical control for bone formation and resorption. by Friederike A. Schulte (406501)

    Published 2013
    “…(D) Mechanical regulation in the CTR group. (E) Sagittal sections through CV6 at (bottom) 0 and (top) 12 weeks after ovariectomy (OVX) (F) OVX causes a strong decrease in BV/TV compared to SHAM-operation (SHM). …”
  12. 18592

    A Randomized Controlled Study on the Effects of Bisoprolol and Atenolol on Sympathetic Nervous Activity and Central Aortic Pressure in Patients with Essential Hypertension by Wei-Jun Zhou (456887)

    Published 2013
    “…</p><p>Methods</p><p>This was a prospective, randomized, controlled study in 109 never-treated hypertensive subjects randomized to bisoprolol (5 mg) or atenolol (50 mg) for 4–8 weeks. …”
  13. 18593

    Hedgehog Signaling Antagonist Promotes Regression of Both Liver Fibrosis and Hepatocellular Carcinoma in a Murine Model of Primary Liver Cancer by George M. Philips (206900)

    Published 2011
    “…Hepatocellular carcinoma (HCC) emerges spontaneously in such mice by 50–60 weeks of age, providing a model of fibrosis-associated hepatocarcinogenesis. …”
  14. 18594

    Table 1_Evaluating the prognostic relevance of neutrophil-to-lymphocyte ratio in cervical cancer: a systematic review and meta-analysis.docx by Xieyan Zhuang (20467625)

    Published 2024
    “…Furthermore, elevated NLR significantly impacted disease-free survival (HR: 1.79, 95% CI: 1.18-2.71; p = 0.006), recurrence rates (HR: 2.18, 95% CI: 1.36-3.51; p = 0.001), recurrence-free survival (HR: 3.05, 95% CI: 1.79-5.19; p < 0.0001), and the incidence of distant metastases (HR: 1.73, 95% CI: 1.20-2.50; p = 0.003).</p>Conclusion<p>An elevated NLR prior to treatment demonstrates a strong association with decreased OS and PFS among patients with cervical cancer, underscoring the significance of NLR as a prognostic marker within this population.…”
  15. 18595

    1,3,2-Dioxathiolane 2,2-Dioxide as a Bifunctional Electrolyte Additive to Enhance the Stability of Lithium Metal Anodes by Yi-Xin Huang (7405004)

    Published 2023
    “…In this work, we report on a new approach utilizing 1,3,2-dioxathiolane 2,2-dioxide (DTD) additives in electrolytes to enhance the performance of LMBs. …”
  16. 18596

    Data_Sheet_2_Effect of Levothyroxine on Blood Pressure in Patients With Subclinical Hypothyroidism: A Systematic Review and Meta-Analysis.doc by Weiwei He (32469)

    Published 2018
    “…Meta-analysis of the 19 prospective follow-up studies found that LT4 therapy significantly decreased SBP and DBP by 4.80 mmHg (95%CI −6.50 to −3.09, P < 0.001) and 2.74 mmHg (95%CI −4.06 to −1.43, P < 0.001), respectively.…”
  17. 18597

    Poly(caprolactone)-Based Coatings on 3D-Printed Biodegradable Implants: A Novel Strategy to Prolong Delivery of Hydrophilic Drugs by Sarah A. Stewart (9198984)

    Published 2020
    “…Implants could be specifically developed in order to match the specific release rate required for a number of drugs for a wide range of conditions.…”
  18. 18598

    Data_Sheet_1_Association of plasma propionate concentration with coronary artery disease in a large cross-sectional study.PDF by Nikolaos Pagonas (306007)

    Published 2023
    “…</p>Results<p>The study included 1,253 patients (median [IQR], 67 [58–76] years; 799 men [64%]). A total of 739 had invasively confirmed CAD with at least one coronary artery stenosis ≥50% and 514 had exclusion of CAD. …”
  19. 18599

    1,3,2-Dioxathiolane 2,2-Dioxide as a Bifunctional Electrolyte Additive to Enhance the Stability of Lithium Metal Anodes by Yi-Xin Huang (7405004)

    Published 2023
    “…In this work, we report on a new approach utilizing 1,3,2-dioxathiolane 2,2-dioxide (DTD) additives in electrolytes to enhance the performance of LMBs. …”
  20. 18600

    Dental developmental complications in pediatric hematopoietic stem cell transplantation patients: A study using CMC clinical data warehouse by Jaehyun Kim (14009967)

    Published 2022
    “…Regression analysis demonstrated that a younger age at initial chemotherapy was a risk factor for tooth agenesis and microdontia.  …”